1. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor

   • Yumei Ye
   • Mandeep Bajaj
   • Yochai Birnbaum

   ORIGINAL ARTICLE 26 April 2017 Pages: 119 - 132

   

2. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats

   • Amritpal Singh
   • Puneet Kaur Randhawa
   • Amteshwar Singh Jaggi

   ORIGINAL ARTICLE 14 February 2017 Pages: 133 - 143

   

3. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture

   • Xiao-Ming Gao
   • Alan Tsai
   • Xiao-Jun Du

   ORIGINAL ARTICLE 15 February 2017 Pages: 145 - 156

   

4. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis

   • Mei-ping Wu
   • Yi-shuai Zhang
   • Chen Yan

   ORIGINAL ARTICLE 20 March 2017 Pages: 157 - 166

   

5. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study

   • Vanessa Pfetsch
   • Veronika Sanin
   • Dietrich Rothenbacher

   ORIGINAL ARTICLE 10 March 2017 Pages: 167 - 177

6. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability

   • Robert S Rosenson
   • Kate Miller
   • Terry A. Jacobson

   ORIGINAL ARTICLE Open access 18 April 2017 Pages: 179 - 186

   

7. Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries

   • Robert S. Rosenson
   • Shravanthi R. Gandra
   • Erik S. Stroes

   ORIGINAL ARTICLE Open access 03 May 2017 Pages: 187 - 195

   

8. Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

   • Gianna Ferretti
   • Tiziana Bacchetti
   • Amirhossein Sahebkar

   REVIEW ARTICLE 07 March 2017 Pages: 197 - 208

   

9. Study Design and Rationale of “A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema”: MIMO Trial

   • Alberto Dominguez-Rodriguez
   • Guillermo Burillo-Putze
   • MIMO investigators

   SHORT COMMUNICATION 07 March 2017 Pages: 209 - 213

   

10. The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action

    • Eirini Lioudaki
    • Emmanouil S. Androulakis
    • Emmanouil S. Ganotakis

    REVIEW ARTICLE 25 April 2017 Pages: 215 - 225

    

11. Melatonin as an Agent for Cardioprotection in Patients with ST-Elevation Myocardial Infarction and Short Ischaemic Time

    • Alberto Dominguez-Rodriguez
    • Pedro Abreu-Gonzalez
    • Russel J. Reiter

    LETTER TO THE EDITOR 18 January 2017 Pages: 227 - 228